Entities / Company
Kras.
Company
- Reports this week
- 0
- Active events
- 0
- Connections
- 16
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
-
FDA approved Rasonque for metastatic PDAC, while Kras and Incyte also developed PDAC inhibitors and Incyte received a CMS settlement benefit.Some support2 reports
-
Kras announced a significant milestone in its growth strategy, involving its expansion and partnership with Walmart.Some support1 report
Gone quiet
No new reports in 90+ daysNo events began in the chosen period. Widen it, or reset.
Around Kras this week
News at the entities that move Kras most-
FDA StructuralNeurogene Inc. developed a gene therapy for Rett syndrome and received FDA agreement for a registrational trial design.Moves Kras
-
Incyte OperationalIncyte is scheduled to present research data at the European Society for Medical Oncology (ESMO) congress in Madrid.Moves Kras
-
Walmart OperationalWalmart is offering Peacock streaming access as part of its bundle, challenging Amazon Prime's pricing.Moves Kras
-
Hoffmann-La Roche OperationalRoche Pharma Vietnam partners with the Bright Future Fund, which is led by Nguyen Thi Xuyen.Moves Kras
Connections
The 5 strongest of 16, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Kalyani Group Structural
Kras and Kalyani Group are linked through a joint venture arrangement.
-
FDA Structural
FDA formally regulates and approves treatments targeting KRAS, dictating market viability for companies in this sector.
-
Hoffmann-La Roche Operational
The two companies are operating in the same competitive market, specifically in lung cancer trials.
-
Walmart Operational
The relationship is currently characterized by operational co-existence, noted as a strategic growth milestone.
-
Incyte Operational
Both companies are actively competing in the development of inhibitors for PDAC.
History
Events by the month they beganAugust 2026
1 eventJuly 2026
3 events- Philadelphia is a major US city as the US invests in fundamental science research focused on KRAS, leveraging institutions like the University of Pennsylvania.
- Kras announced a significant milestone in its growth strategy, involving its expansion and partnership with Walmart.
- A KRAS drug has demonstrated superior results compared to rivals in a lung cancer clinical trial.